Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 348

1.

Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008.

Patel MR, Marso SP, Dai D, Anstrom KJ, Shunk KA, Curtus JP, Brennan JM, Sedrakyan A, Messenger JC, Douglas PS.

JACC Cardiovasc Interv. 2012 Oct;5(10):1054-61. doi: 10.1016/j.jcin.2012.05.017.

2.

Long-term outcome of percutaneous coronary intervention for chronic total occlusions.

Mehran R, Claessen BE, Godino C, Dangas GD, Obunai K, Kanwal S, Carlino M, Henriques JP, Di Mario C, Kim YH, Park SJ, Stone GW, Leon MB, Moses JW, Colombo A; Multinational Chronic Total Occlusion Registry.

JACC Cardiovasc Interv. 2011 Sep;4(9):952-61. doi: 10.1016/j.jcin.2011.03.021.

3.

Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry.

Kutcher MA, Brennan JM, Rao SV, Dai D, Anstrom KJ, Mustafa N, Sedrakyan A, Booth ME, Douglas PS, Messenger JC.

Catheter Cardiovasc Interv. 2014 Feb;83(2):171-81. doi: 10.1002/ccd.25108. Epub 2013 Aug 31. Erratum in: Catheter Cardiovasc Interv. 2014 Jul 1;84(1):168. Sedrakayan, Art [corrected to Sedrakyan].

PMID:
23907981
4.

Long-term efficacy and safety of drug-eluting stent implantation for patients with multiple coronary chronic total occlusions.

Zhang J, Han YL, Li Y, Wang SL, Jing QM, Wang XZ, Ma YY, Luan B, Wang G, Wang B.

Chin Med J (Engl). 2010 Apr 5;123(7):789-93.

PMID:
20497665
5.

3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.

De Felice F, Fiorilli R, Parma A, Nazzaro M, Musto C, Sbraga F, Caferri G, Violini R.

JACC Cardiovasc Interv. 2009 Dec;2(12):1260-5. doi: 10.1016/j.jcin.2009.09.013.

6.

Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States.

Wang TY, Masoudi FA, Messenger JC, Shunk KA, Boyle A, Brennan JM, Anderson HV, Anstrom KJ, Dai D, Peterson ED, Douglas PS, Rumsfeld JS.

J Am Coll Cardiol. 2012 Jan 10;59(2):105-12. doi: 10.1016/j.jacc.2011.10.853.

7.

Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.

Han YL, Zhang J, Li Y, Wang SL, Jing QM, Yi XH, Ma YY, Luan B, Wang G, Wang B.

Chin Med J (Engl). 2009 Mar 20;122(6):643-7.

PMID:
19323927
8.

Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.

Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E.

Arch Cardiovasc Dis. 2013 Nov;106(11):554-61. doi: 10.1016/j.acvd.2013.06.056. Epub 2013 Nov 11.

9.

Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.

Brodie BR, Wilson H, Stuckey T, Nussbaum M, Laurent S, Bradshaw B, Humphrey A, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Simonton CA; STENT Group.

JACC Cardiovasc Interv. 2009 Nov;2(11):1105-12. doi: 10.1016/j.jcin.2009.08.020.

10.

Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction.

Hannan EL, Racz M, Walford G, Holmes DR, Jones RH, Sharma S, Katz S, King SB 3rd.

JACC Cardiovasc Interv. 2008 Apr;1(2):129-35. doi: 10.1016/j.jcin.2008.01.006.

11.

Major adverse cardiovascular events after drug-eluting stent implantation in patients with single chronic total occlusion: a single-center registry.

Gilis-Siek N, Fijalkowski M, Jaguszewski M, Targonski R, Strozyk A, Cackowska M, Masiewicz E, Skarzynski P, Burakowski S, Chmielecki M, Lewicki L, Dubaniewicz W, Gruchala M, Ciecwierz D, Rynkiewicz A.

J Invasive Cardiol. 2013 Nov;25(11):567-72.

12.

Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.

Aggarwal V, Stanislawski MA, Maddox TM, Nallamothu BK, Grunwald G, Adams JC, Ho PM, Rao SV, Casserly IP, Rumsfeld JS, Brilakis ES, Tsai TT.

J Am Coll Cardiol. 2014 Oct 28;64(17):1825-36. doi: 10.1016/j.jacc.2014.06.1207. Epub 2014 Oct 21.

13.

Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.

Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ, Choo SJ, Chung CH, Lee JW, Park SW, Park SJ.

J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097.

14.

In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.

Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF; EVENT Investigators.

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1127-36. doi: 10.1002/ccd.24352. Epub 2012 May 4.

PMID:
22431166
15.
16.

A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients.

Minha S, Bental T, Assali A, Vaknin-Assa H, Lev EI, Rechavia E, Battler A, Kornowski R.

Catheter Cardiovasc Interv. 2011 Nov 1;78(5):710-7. doi: 10.1002/ccd.23062. Epub 2011 Jul 29.

PMID:
21805561
17.

Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.

JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.

18.

Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.

Abbott JD, Voss MR, Nakamura M, Cohen HA, Selzer F, Kip KE, Vlachos HA, Wilensky RL, Williams DO.

J Am Coll Cardiol. 2007 Nov 20;50(21):2029-36.

19.

Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.

Onuma Y, Kukreja N, Daemen J, Garcia-Garcia HM, Gonzalo N, Cheng JM, van Twisk PH, van Domburg R, Serruys PW; Interventional Cardiologists of Thoraxcenter.

JACC Cardiovasc Interv. 2009 Jul;2(7):603-10. doi: 10.1016/j.jcin.2009.03.016.

20.

Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort.

Anderson ML, Peterson ED, Brennan JM, Rao SV, Dai D, Anstrom KJ, Piana R, Popescu A, Sedrakyan A, Messenger JC, Douglas PS.

Circulation. 2012 Oct 30;126(18):2190-9. doi: 10.1161/CIRCULATIONAHA.112.111369. Epub 2012 Sep 17.

Supplemental Content

Support Center